Developer docs
API playgroundTry for free, no card

Search company profiles

Accsys Technology

Full company profile

uuid000ql13

Namestring
Accsys Technology
Legal namestring
AccSys Technology, Inc.
Websiteurl
accsys.com
Company typeenum
Private
Founded yearint
1985
Descriptiontext

AccSys Technology, Inc. is an integrated design and manufacturing firm specializing in ion linear accelerator (linac) systems for medical, industrial, and research applications. Founded in 1985 and headquartered at 1177 Quarry Lane, Pleasanton, California, the company builds compact proton and ion accelerators based on proprietary radiofrequency quadrupole (RFQ) and drift-tube linac (DTL) technology, protected by two foundational US patents — US 5,315,120 ("Univane" RFQ design) and US 5,179,350 (DTL mounting scheme). Its product portfolio spans four lines: PULSAR® (compact proton linacs for PET isotope production in hospitals), LANSAR® (linear-accelerator-based neutron generators for non-destructive inspection), LiNSTAR™ (synchrotron injector linacs at 2–7 MeV for proton therapy and research), and Custom Linacs (high-current pulsed proton systems from 2 MeV to above 100 MeV), supported by shared subsystems including RF power systems (150–600 MHz, 25–360 kW peak power).

The company sells directly to a global base of hospitals, research institutions, and industrial customers through a project-oriented sales approach that bundles system design, facility planning, flexible financing, installation, operator training, warranty, and service contracts. Hardware is delivered as complete systems or as modular subsystems that support field upgrades — e.g., PULSAR 7 to PULSAR 11 — creating a recurring aftermarket revenue layer on top of one-time capital sales. Reference customers include Loma Linda University Proton Cancer Treatment Center (continuous operation since 1990), Brookhaven National Laboratory (joint R&D partner on PULSAR targets and chemistry), and Hitachi General Hospital (first PULSAR 7 installation in 2004).

AccSys Technology was demerged from Performance Controls, Inc. — a Hitachi, Ltd. division — and became an independent corporation on April 1, 2020, while remaining wholly owned by Hitachi, Ltd. (TSE: 6501). It operates as a private subsidiary of a Japanese conglomerate with no disclosed venture capital or private equity investment, ~51–100 employees, and no publicly disclosed revenue. Its competitive position is anchored by decades of installed-base credibility, patented core technology, and a cost architecture that competes with traditional cyclotrons on footprint, lifecycle cost, and decommissioning burden.

Short descriptiontext

AccSys Technology, Inc. designs and manufactures ion linear accelerator systems (RFQ and DTL) for PET isotope production, neutron generation, and synchrotron injection, serving hospitals, research labs, and industrial customers worldwide from Pleasanton, California. Wholly owned by Hitachi, Ltd.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPleasanton, United States
HQ citystring
Pleasanton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ion linear accelerators, proton linac systems, PET isotope production, neutron generators, synchrotron injectors
Industry1 code
PRIMARYHLAIAGAD
Radioisotope Production (Reactor/Cyclotron/Gamma)
Healthcare & Life Sciences/Pharmaceuticals/Radiopharmaceuticals & Nuclear Medicine
NAICS code2 codes
  • Irradiation Apparatus Manufacturing334517
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • X-Ray Apparatus & Tubes & Related Irradiation Apparatus3844
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Particle Accelerator Systems / Ion Linear Accelerators
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Linear Accelerator Hardware Sales
TypeOne Time License
Description

AccSys generates revenue through the sale of ion linear accelerator systems, including standard product lines (PULSAR, LANSAR, LiNSTAR) and custom-designed systems. Hardware includes RFQ linacs, DTL linacs, and RF power systems as complete systems or subsystems.

accsys.com
2Professional Services and Support
TypeProfessional Services
Description

Revenue from comprehensive customer support including design services, facility planning, equipment installation, operator training, warranty programs, and service contract options.

accsys.com
3System Upgrades and Reconfiguration
TypeSubscription Recurring
Description

Modular subsystem design allows customers to upgrade features, functions and performance from PULSAR 7 to PULSAR 11 and higher energy systems, providing ongoing revenue opportunities.

accsys.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Supply Chain, Others
Pricing details1 tier
1Custom quote-based pricing for ion linear accelerator systems
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Pricing is provided upon contact based on customer specifications and system configuration. The company offers flexible financing plans.

accsys.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1PULSAR®
Description

Compact proton linac systems for cost-effective production of radiotracers for Positron Emission Tomography (PET) imaging applications.

accsys.com
+2 more records
Core offering1 text field

AccSys Technology designs, manufactures, installs, and services ion linear accelerator (linac) systems based on its patented RFQ linac and drift-tube linac (DTL) technology. It sells compact proton linac systems for PET isotope production (PULSAR®), linac-based neutron generators for industrial and research use (LANSAR®), ion linacs for synchrotron injection in proton therapy and physics research (LiNSTAR™), and custom-engineered high-current pulsed proton linacs (PL-Series / Custom Linacs), with supporting RF power systems.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Systems can be installed in less than 1,000 ft² for complete PET radiotracer production facility
+3 more records
Product overview1 text field

AccSys Technology is an integrated design and manufacturing company specializing in ion linear accelerator (linac) systems using radiofrequency quadrupole (RFQ) linac and drift-tube linac (DTL) technology. The company's product portfolio consists of four core branded systems: PULSAR® (PET isotope production linacs for medical imaging), LANSAR® (neutron generators for industrial/research applications), LiNSTAR™ (synchrotron injector linacs for proton beam therapy and physics research), and Custom Linacs (tailored systems for specialized ion beam applications). These products share common underlying technology components including proprietary RFQ linacs, DTL, and RF power systems. AccSys serves customers in medicine, industry, and research worldwide.

Product and service4 records
1PULSAR® PET Isotope Production Systems
CategoryMedical / PET Isotope Production
Description

Compact proton linac-based systems for the cost-effective production of positron emitting radiotracers (fluorine-18 and carbon-11) used in Positron Emission Tomography (PET) imaging for oncology, cardiology, neurology, and molecular imaging. Available as standalone installations or in mobile configurations inside standard 48 ft trailers. Designed for hospitals and medical imaging centers that need reliable PET isotope supply without the footprint, cost, or decommissioning burden of a traditional cyclotron.

2LANSAR® Neutron Generator Systems
CategoryIndustrial / Neutron Generation
Description

Versatile line of linear-accelerator-based compact neutron generators for non-destructive inspection applications. Uses AccSys' patented linac technology with customer-supplied targets, with no radioactive materials, rugged transportable construction, computerized control and monitoring, and variable intensity and pulse structure. Built for reliable long-term operation in research and industrial environments.

3LiNSTAR™ Synchrotron Injector Systems
CategoryMedical Physics / Research Accelerators
Description

Family of ion linac systems engineered to inject ion beams into synchrotrons used in proton beam cancer therapy and physics research. Standard systems deliver output beam energies from 2 to 7 MeV, with higher injection energies available as custom configurations. Targeted at hospitals with proton therapy programs and physics research institutions operating synchrotron facilities.

4Custom Linacs (PL-Series High-Current Pulsed Proton Linacs)
CategoryCustom Particle Accelerator Systems
Description

Custom-engineered high-current pulsed proton linacs delivering a wide range of peak and average currents at energies from 2 MeV to above 100 MeV. Pulse width, energy, and current can be varied from pulse to pulse so a single accelerator can serve multiple targets or applications. Built from modular subsystems (RFQ linacs, DTL, RF power systems, HEBT, buncher cavities) tailored to customer specifications for synchrotron injection, isotope production research, and specialized physics and industrial uses.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-04-01
Description

Former parent company that demerged AccSys Technology as an independent company effective April 1, 2020. AccSys was previously part of Performance Controls, Inc., a division of Hitachi, Ltd. The demerger was part of Hitachi's sale of diagnostic imaging businesses announced December 18, 2019. AccSys continues to operate as wholly owned by Hitachi Ltd. with same 'ship to' and 'bill to' addresses.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint research and development agreement for PULSAR isotope production targets and chemistry systems. The PET chemistry group at Brookhaven National Laboratory collaborated with AccSys on developing precision, high performance targets and radiotracer synthesis units that are efficient, reliable and easy to use.

Strategic tierMinorTypeOEM/ Whitelabel/ Licensing Partner
Description

Partnership for Mobile PET Isotope Production Lab. Medical Coaches provides the trailer that contains the linac room and laboratory area with clean room for manufacturing, dispensing FDG and chemical handling. The Mobile PULSAR 7 is provided in a standard 48 ft trailer configuration.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Developer of accelerator-based neutron sources for boron neutron capture therapy (BNCT). Uses linac technology similar in principle to AccSys's LANSAR neutron generator platform, targeting emerging clinical and research BNCT applications.

TypeBroad incumbent
Description

Major radiation oncology vendor now owned by Siemens Healthineers, active in proton therapy systems and imaging for treatment planning. Competes with AccSys's LiNSTAR injector business indirectly through integrated proton therapy platform offerings.

TypeEmerging player
Description

US-based developer of compact single-room proton therapy systems that compete with traditional synchrotron-based proton centers. Adjacent to AccSys LiNSTAR because proton therapy center growth drives demand for both injector linacs and competing delivery architectures.

4IBA (Ion Beam Applications)
TypeDirect peer
Description

Belgian leader in PET radioisotope cyclotrons and proton therapy systems. Directly competes with AccSys PULSAR in medical PET isotope production and with LiNSTAR in proton therapy injector/accelerator supply.

TypeBroad incumbent
Description

Global medical technology company with PET imaging hardware, radiopharmacy solutions, and (post-Varian acquisition) proton therapy and radiation oncology. Overlaps with AccSys PULSAR in PET isotope production and with LiNSTAR through Varian's particle therapy footprint.

TypeDirect peer
Description

US-based designer and manufacturer of medical cyclotrons, primarily for PET isotope production and proton therapy. Competes head-to-head with AccSys PULSAR for hospital and research site PET installations.

TypeBroad incumbent
Description

Large medical imaging OEM with an established PET radiopharmacy/cyclotron business (historically via PETtrace) and broader molecular imaging portfolio. Competes with AccSys PULSAR through entrenched cyclotron installations and integrated radiopharmacy service offerings.

TypeDirect peer
Description

Japan-based manufacturer of medical cyclotrons for PET isotopes and proton therapy systems. Closely comparable to AccSys across both the PULSAR product line and the LiNSTAR synchrotron injector business.

TypeEmerging player
Description

Compact proton therapy system developer targeting single-room installations. Indirectly comparable to AccSys because both target smaller, lower-cost proton therapy deployments, though at different layers of the delivery stack.

TypeOthers
Description

AccSys's parent company, which operates its own proton beam therapy systems business. Relevant as the corporate parent providing capital, channels, and Hitachi General Hospital as a reference customer, while also fielding competing particle therapy technology.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Accsys Technology

Particle Accelerator Systems / Ion Linear Acceleratorsaccsys.com

AccSys Technology, Inc. designs and manufactures ion linear accelerator systems (RFQ and DTL) for PET isotope production, neutron generation, and synchrotron injection, serving hospitals, research labs, and industrial customers worldwide from Pleasanton, California. Wholly owned by Hitachi, Ltd.

What Accsys Technology does

AccSys Technology, Inc. is an integrated design and manufacturing firm specializing in ion linear accelerator (linac) systems for medical, industrial, and research applications. Founded in 1985 and headquartered at 1177 Quarry Lane, Pleasanton, California, the company builds compact proton and ion accelerators based on proprietary radiofrequency quadrupole (RFQ) and drift-tube linac (DTL) technology, protected by two foundational US patents — US 5,315,120 ("Univane" RFQ design) and US 5,179,350 (DTL mounting scheme). Its product portfolio spans four lines: PULSAR® (compact proton linacs for PET isotope production in hospitals), LANSAR® (linear-accelerator-based neutron generators for non-destructive inspection), LiNSTAR™ (synchrotron injector linacs at 2–7 MeV for proton therapy and research), and Custom Linacs (high-current pulsed proton systems from 2 MeV to above 100 MeV), supported by shared subsystems including RF power systems (150–600 MHz, 25–360 kW peak power).

The company sells directly to a global base of hospitals, research institutions, and industrial customers through a project-oriented sales approach that bundles system design, facility planning, flexible financing, installation, operator training, warranty, and service contracts. Hardware is delivered as complete systems or as modular subsystems that support field upgrades — e.g., PULSAR 7 to PULSAR 11 — creating a recurring aftermarket revenue layer on top of one-time capital sales. Reference customers include Loma Linda University Proton Cancer Treatment Center (continuous operation since 1990), Brookhaven National Laboratory (joint R&D partner on PULSAR targets and chemistry), and Hitachi General Hospital (first PULSAR 7 installation in 2004).

AccSys Technology was demerged from Performance Controls, Inc. — a Hitachi, Ltd. division — and became an independent corporation on April 1, 2020, while remaining wholly owned by Hitachi, Ltd. (TSE: 6501). It operates as a private subsidiary of a Japanese conglomerate with no disclosed venture capital or private equity investment, ~51–100 employees, and no publicly disclosed revenue. Its competitive position is anchored by decades of installed-base credibility, patented core technology, and a cost architecture that competes with traditional cyclotrons on footprint, lifecycle cost, and decommissioning burden.

Accsys Technology firmographics

Firmographics
Name
Accsys Technology
Legal name
AccSys Technology, Inc.
Website
https://accsys.com
Company type
Private
Founded year
1985
Operating status
Operating
Headcount range
11–50 employees
Short description
AccSys Technology, Inc. designs and manufactures ion linear accelerator systems (RFQ and DTL) for PET isotope production, neutron generation, and synchrotron injection, serving hospitals, research labs, and industrial customers worldwide from Pleasanton, California. Wholly owned by Hitachi, Ltd.
Ownership category
akta.pro rank

Accsys Technology industry classification

Industry
Product category
Particle Accelerator Systems / Ion Linear Accelerators
NAICS
Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAIAGAD
Radioisotope Production (Reactor/Cyclotron/Gamma)
Healthcare & Life Sciences/Pharmaceuticals/Radiopharmaceuticals & Nuclear Medicine

Keywords

  • Ion linear accelerators
  • Proton linac systems
  • PET isotope production
  • Neutron generators
  • Synchrotron injectors

Where Accsys Technology is headquartered

Location

Headquarters

HQ city
Pleasanton
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Accsys Technology business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Others

Revenue model

  1. Linear Accelerator Hardware Sales: AccSys generates revenue through the sale of ion linear accelerator systems, including standard product lines (PULSAR, LANSAR, LiNSTAR) and custom-designed systems. Hardware includes RFQ linacs, DTL linacs, and RF power systems as complete systems or subsystems.
  2. Professional Services and Support: Revenue from comprehensive customer support including design services, facility planning, equipment installation, operator training, warranty programs, and service contract options.
  3. System Upgrades and Reconfiguration: Modular subsystem design allows customers to upgrade features, functions and performance from PULSAR 7 to PULSAR 11 and higher energy systems, providing ongoing revenue opportunities.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractCustom quote-based pricing for ion linear accelerator systems

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Accsys Technology product offering

Product offering

Core offering

AccSys Technology designs, manufactures, installs, and services ion linear accelerator (linac) systems based on its patented RFQ linac and drift-tube linac (DTL) technology. It sells compact proton linac systems for PET isotope production (PULSAR®), linac-based neutron generators for industrial and research use (LANSAR®), ion linacs for synchrotron injection in proton therapy and physics research (LiNSTAR™), and custom-engineered high-current pulsed proton linacs (PL-Series / Custom Linacs), with supporting RF power systems.

Product overview

AccSys Technology is an integrated design and manufacturing company specializing in ion linear accelerator (linac) systems using radiofrequency quadrupole (RFQ) linac and drift-tube linac (DTL) technology. The company's product portfolio consists of four core branded systems: PULSAR® (PET isotope production linacs for medical imaging), LANSAR® (neutron generators for industrial/research applications), LiNSTAR™ (synchrotron injector linacs for proton beam therapy and physics research), and Custom Linacs (tailored systems for specialized ion beam applications). These products share common underlying technology components including proprietary RFQ linacs, DTL, and RF power systems. AccSys serves customers in medicine, industry, and research worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • PULSAR®: Compact proton linac systems for cost-effective production of radiotracers for Positron Emission Tomography (PET) imaging applications.
  • LANSAR®
  • LiNSTAR™

Products and services

  • PULSAR® PET Isotope Production Systems Compact proton linac-based systems for the cost-effective production of positron emitting radiotracers (fluorine-18 and carbon-11) used in Positron Emission Tomography (PET) imaging for oncology, cardiology, neurology, and molecular imaging. Available as standalone installations or in mobile configurations inside standard 48 ft trailers. Designed for hospitals and medical imaging centers that need reliable PET isotope supply without the footprint, cost, or decommissioning burden of a traditional cyclotron.
  • LANSAR® Neutron Generator Systems Versatile line of linear-accelerator-based compact neutron generators for non-destructive inspection applications. Uses AccSys' patented linac technology with customer-supplied targets, with no radioactive materials, rugged transportable construction, computerized control and monitoring, and variable intensity and pulse structure. Built for reliable long-term operation in research and industrial environments.
  • LiNSTAR™ Synchrotron Injector Systems Family of ion linac systems engineered to inject ion beams into synchrotrons used in proton beam cancer therapy and physics research. Standard systems deliver output beam energies from 2 to 7 MeV, with higher injection energies available as custom configurations. Targeted at hospitals with proton therapy programs and physics research institutions operating synchrotron facilities.
  • Custom Linacs (PL-Series High-Current Pulsed Proton Linacs) Custom-engineered high-current pulsed proton linacs delivering a wide range of peak and average currents at energies from 2 MeV to above 100 MeV. Pulse width, energy, and current can be varied from pulse to pulse so a single accelerator can serve multiple targets or applications. Built from modular subsystems (RFQ linacs, DTL, RF power systems, HEBT, buncher cavities) tailored to customer specifications for synchrotron injection, isotope production research, and specialized physics and industrial uses.

Quantifiable outcome

  • Systems can be installed in less than 1,000 ft² for complete PET radiotracer production facility
  • +3 more outcomes

Companies that use Accsys Technology

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Accsys Technology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Accsys Technology partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor and core.

  • Hitachi, Ltd.minorStrategic or Co-development Partner · 1 April 2020Former parent company that demerged AccSys Technology as an independent company effective April 1, 2020. AccSys was previously part of Performance Controls, Inc., a division of Hitachi, Ltd. The demerger was part of Hitachi's sale of diagnostic imaging businesses announced December 18, 2019. AccSys continues to operate as wholly owned by Hitachi Ltd. with same 'ship to' and 'bill to' addresses.
  • Brookhaven National LaboratorycoreStrategic or Co-development PartnerJoint research and development agreement for PULSAR isotope production targets and chemistry systems. The PET chemistry group at Brookhaven National Laboratory collaborated with AccSys on developing precision, high performance targets and radiotracer synthesis units that are efficient, reliable and easy to use.
  • Medical CoachesminorOEM/ Whitelabel/ Licensing PartnerPartnership for Mobile PET Isotope Production Lab. Medical Coaches provides the trailer that contains the linac room and laboratory area with clean room for manufacturing, dispensing FDG and chemical handling. The Mobile PULSAR 7 is provided in a standard 48 ft trailer configuration.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Accsys Technology competitors and assessment

Company assessment

Emerging players

  • Neutron Therapeutics: Developer of accelerator-based neutron sources for boron neutron capture therapy (BNCT). Uses linac technology similar in principle to AccSys's LANSAR neutron generator platform, targeting emerging clinical and research BNCT applications.
  • Mevion Medical Systems: US-based developer of compact single-room proton therapy systems that compete with traditional synchrotron-based proton centers. Adjacent to AccSys LiNSTAR because proton therapy center growth drives demand for both injector linacs and competing delivery architectures.
  • ProNova Solutions: Compact proton therapy system developer targeting single-room installations. Indirectly comparable to AccSys because both target smaller, lower-cost proton therapy deployments, though at different layers of the delivery stack.

Broad incumbents

  • Varian Medical Systems (a Siemens Healthineers company): Major radiation oncology vendor now owned by Siemens Healthineers, active in proton therapy systems and imaging for treatment planning. Competes with AccSys's LiNSTAR injector business indirectly through integrated proton therapy platform offerings.
  • Siemens Healthineers: Global medical technology company with PET imaging hardware, radiopharmacy solutions, and (post-Varian acquisition) proton therapy and radiation oncology. Overlaps with AccSys PULSAR in PET isotope production and with LiNSTAR through Varian's particle therapy footprint.
  • GE HealthCare: Large medical imaging OEM with an established PET radiopharmacy/cyclotron business (historically via PETtrace) and broader molecular imaging portfolio. Competes with AccSys PULSAR through entrenched cyclotron installations and integrated radiopharmacy service offerings.

Direct peers

  • IBA (Ion Beam Applications): Belgian leader in PET radioisotope cyclotrons and proton therapy systems. Directly competes with AccSys PULSAR in medical PET isotope production and with LiNSTAR in proton therapy injector/accelerator supply.
  • Best Cyclotron Systems: US-based designer and manufacturer of medical cyclotrons, primarily for PET isotope production and proton therapy. Competes head-to-head with AccSys PULSAR for hospital and research site PET installations.
  • Sumitomo Heavy Industries: Japan-based manufacturer of medical cyclotrons for PET isotopes and proton therapy systems. Closely comparable to AccSys across both the PULSAR product line and the LiNSTAR synchrotron injector business.

Others

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Accsys Technology social profiles

Digital presence

Accsys Technology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Accsys Technology leadership team

Management profile

Number of profiles

Accsys Technology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Accsys Technology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Accsys Technology

What does Accsys Technology do?

AccSys Technology designs, manufactures, installs, and services ion linear accelerator (linac) systems based on its patented RFQ linac and drift-tube linac (DTL) technology. It sells compact proton linac systems for PET isotope production (PULSAR®), linac-based neutron generators for industrial and research use (LANSAR®), ion linacs for synchrotron injection in proton therapy and physics research (LiNSTAR™), and custom-engineered high-current pulsed proton linacs (PL-Series / Custom Linacs), with supporting RF power systems.

Is Accsys Technology a public or private company?

Accsys Technology is a private company. It is classified as corporate owned and is currently operating.

When was Accsys Technology founded?

Accsys Technology was founded in 1985. It employs 11 to 50 people.

Where is Accsys Technology based?

Accsys Technology is headquartered in Pleasanton, United States, in the North America region.

How does Accsys Technology make money?

Three revenue lines are on record. Linear Accelerator Hardware Sales are the primary driver. The others are professional Services and Support and system Upgrades and Reconfiguration.

Who are Accsys Technology's main competitors?

Emerging players on record are Neutron Therapeutics, Mevion Medical Systems and ProNova Solutions. Broad incumbents are Varian Medical Systems (a Siemens Healthineers company), Siemens Healthineers and GE HealthCare. Direct peers are IBA (Ion Beam Applications), Best Cyclotron Systems and Sumitomo Heavy Industries. Hitachi, Ltd. (parent group and adjacent particle therapy business) is listed as an others.

Does Accsys Technology have an API?

No public API is recorded for Accsys Technology.

What industry is Accsys Technology in?

Accsys Technology's product category is Particle Accelerator Systems / Ion Linear Accelerators. Its primary akta.pro industry code is HLAIAGAD, Radioisotope Production (Reactor/Cyclotron/Gamma). Its NAICS code is 334517 and its SIC code is 3844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales